Wyeth has informed that a meeting of the Board of Directors of the Company will be held on November 23, 2013, to consider a Scheme of Amalgamation of the Company with Pfizer Limited and to consider declaration of Interim Dividend.
The above information is a part of company’s filings submitted to BSE.